U.S. Markets closed
  • S&P Futures

    4,144.25
    -2.00 (-0.05%)
     
  • Dow Futures

    34,183.00
    0.00 (0.00%)
     
  • Nasdaq Futures

    13,328.25
    -17.75 (-0.13%)
     
  • Russell 2000 Futures

    2,202.70
    -0.60 (-0.03%)
     
  • Crude Oil

    65.51
    +0.23 (+0.35%)
     
  • Gold

    1,836.40
    +0.30 (+0.02%)
     
  • Silver

    27.68
    +0.02 (+0.08%)
     
  • EUR/USD

    1.2149
    -0.0003 (-0.0243%)
     
  • 10-Yr Bond

    1.6240
    +0.0220 (+1.37%)
     
  • Vix

    21.84
    +2.18 (+11.09%)
     
  • GBP/USD

    1.4138
    -0.0005 (-0.0382%)
     
  • USD/JPY

    108.7100
    +0.0900 (+0.0829%)
     
  • BTC-USD

    56,701.75
    +873.49 (+1.56%)
     
  • CMC Crypto 200

    1,528.02
    +1,285.34 (+529.65%)
     
  • FTSE 100

    6,947.99
    -175.69 (-2.47%)
     
  • Nikkei 225

    28,608.59
    -909.71 (-3.08%)
     

German scientist: J&J to cooperate in study of rare clots linked to COVID-19 vaccine

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

ZURICH, April 20 (Reuters) - A German scientist studying rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday that Johnson & Johnson had agreed to collaborate with him on research into similar events associated with its own COVID-19 shot.

"We agreed today with the company that we will work together," Andreas Greinacher, a scientist at Greifswald University, said during a press conference where he outlined his work seeking to explain the causes of the very rare clots that developed in people given AstraZeneca's shot.

Greinacher's comments came as J&J said it stood ready to restart its COVID-19 vaccine in Europe, where the region's medical regulator on Tuesday said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots. (Reporting by John Miller)